Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatitis induced by mesalamine.

F Erdkamp1, M Houben, E Ackerman

  • 1Department of Internal Medicine, Catharina Hospital, Eindhoven, Netherlands.

The Netherlands Journal of Medicine
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome.

Journal of intellectual disability research : JIDR·2024
Same author

The influence of size and comminution of the posterior malleolus fragment on gait in trimalleolar ankle fractures.

Clinical biomechanics (Bristol, Avon)·2021
Same author

[Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome].

Tijdschrift voor psychiatrie·2020
Same author

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry.

Acta oncologica (Stockholm, Sweden)·2019
Same author

Molecular characterization of type 1 porcine reproductive and respiratory syndrome viruses (PRRSV) isolated in the Netherlands from 2014 to 2016.

PloS one·2019
Same author

Porcine epidemic diarrhea virus (PEDV) introduction into a naive Dutch pig population in 2014.

Veterinary microbiology·2018

Mesalamine, a 5-aminosalicylic acid agent, can cause pancreatitis in patients with inflammatory bowel disease. This risk was confirmed in a patient who experienced pancreatitis upon rechallenge with mesalamine.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Toxicology

Background:

  • Sulphasalazine is a common treatment for chronic inflammatory bowel disease (IBD).
  • Pancreatitis is a known side effect of sulphasalazine.
  • Newer 5-aminosalicylic acid (5-ASA) agents are considered effective and safer alternatives.

Observation:

  • This report details a case of a patient treated for IBD.
  • The patient developed pancreatitis.
  • The pancreatitis was linked to mesalamine, a 5-ASA agent.

Findings:

  • Mesalamine, a 5-ASA drug, was identified as the cause of pancreatitis in this IBD patient.
  • Rechallenge with mesalamine confirmed the causal link to pancreatitis.
  • This finding challenges the assumption that all 5-ASA agents are significantly less toxic than sulphasalazine.

Related Experiment Videos

Implications:

  • Clinicians should be aware of the potential for mesalamine-induced pancreatitis in IBD patients.
  • Further research may be needed to fully characterize the toxicity profiles of different 5-ASA agents.
  • This case highlights the importance of considering drug-induced pancreatitis in IBD management.